The CAROLINA and CARMELINA Trials offer further information regarding the CV safety of linagliptin and glimepiride among patients with T2DM, high CVD risk, and decreased renal function.
Read More »CREDENCE Trial – Overlooked Benefits In Preventing CVD
SGLT2 Inhibitors and their use for preventing cardiovascular diseases.
Read More »Long-Term Lactation Benefits for Gestational Diabetes Patients
Breastfeeding has many known long-term benefits, which include the reduction of the risk of a major disease state.
Read More »Liraglutide Use in Youth with Type 2 Diabetes
Results from a phase 3 trial investigating the use of liraglutide in children and adolescents.
Read More »How Adipose Tissue Impacts Exercise Tolerance
Can the amount of fat on the heart impact a person’s tolerance for exercise?
Read More »Diabetes May Be a Risk Factor in All-Cause Mortality
Individuals with a high glucose variability are at risk of developing high-mortality conditions such as arteriosclerosis and sustained hyperglycemic episodes.
Read More »Cognitive Decline: Just Life, or a Preventable Disease?
Cognitive decline is associated with many diseases and medications, but the exact mechanisms are not clearly understood.
Read More »How High-Intensity Workouts Affect Adolescents with T1D
High-intensity workouts can result in grave medical conditions for adolescents with type 1 diabetes.
Read More »Depression and Hyperglycemic Crisis
People who have diabetes and depression have a higher risk of complications from both diseases.
Read More »Diabetes and Birth Outcomes
Pregnancy can be affected by diabetes, but are the outcomes as serious as we believe?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.